Schedule 13D ownership disclosure

Amarantus Bioscience Holdings, Inc.

Security class unavailable · CUSIP: 02300U205

Event date: 2022-04-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
14,176,424
Percent of class
4.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001753926-22-000545
Form type
SC 13D/A
Filer
Amarantus Bioscience Holdings, Inc.
CIK
CIK 1424812
Filed
Apr 18, 2022
Reporting period
Apr 18, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub